{"id":"BE54AF93-2B0D-411D-BBC7-CDFED92E21AB","title":"Biomedical Catalyst â€“ Smart Combination Respiratory Medicines for Optimal &amp; Cost Effective Patient Benefit","abstractText":"The Business-led APPS2B Project aims to identify, demonstrate, and quantify for the first time the mechanism for, and potential significant clinical benefits of highly innovative orally inhaled combination respiratory therapies, that have been optimally designed, engineered and manufactured for intent using Prosonix Multi-Component Particle (MCP) Technology.","grantUrl":"http://gtr.rcuk.ac.uk/projects?ref=MC_PC_13033","grantId":"MC_PC_13033","fundValue":"0","fundStart":"2013-01-01","fundEnd":"2014-06-30","funder":"MRC","impactText":"","person":"Omar S Usmani","coPersons":[],"organisation":"Imperial College London","findingsText":"","dataset":"gtr"}